Novel Management Approach to Oral Leukoplakia: Topical Imiquimod Treatment
Malak Al‐Hadlaq(Dana-Farber Cancer Institute), Sook‐Bin Woo(Dana-Farber Brigham Cancer Center), Alessandro Villa(Mario Negri Institute for Pharmacological Research), Piamkamon Vacharotayangul(Brigham and Women's Hospital), NATHANIEL TREISTER(Brigham and Women's Hospital), HERVE SROUSSI(Dana-Farber Cancer Institute), Michele Lodolo(University of California, San Francisco), Anette Vistoso Monreal(University of Southern California), KENTARO IKEDA(Dana-Farber Cancer Institute), Piri Veluppillai(University of California, San Francisco)
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
November 1, 2023
Cited by 4
Related Papers
The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women’s Cancer Center Multidisciplinary Guideline
|The Oncologist|2017|96
Dental patients’ self-reports of xerostomia and associated risk factors
|The Journal of the American Dental Association|2011|85
Oral lichen planus: comparative efficacy and treatment costs—a systematic review
|BMC Oral Health|2022|69
Common Oral Conditions
|JAMA|2024|68
Nivolumab for Patients With High-Risk Oral Leukoplakia
|JAMA Oncology|2023|56